Tech Company Financing Transactions
VCCT Funding Round
VCCT closed a $4 million funding round on 11/16/2023. Investors included Dai-Dan, Sysmex Corporation and YASKAWA.
Transaction Overview
Company Name
Announced On
11/16/2023
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the development of retinal regenerative medicine.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2-1-8 Minatojima-minamimachi, Chuo-ku
Kobe, 650-0047
JP
Kobe, 650-0047
JP
Phone
Undisclosed
Website
Email Address
Overview
VCCT Inc. was established in March2021 as a wholly owned subsidiary of Vision Care Inc. (certified as a RIKEN Venture). The Company conducts research and development in the fields of ophthalmology and regenerative medicine for the purpose of research and development of technologies related to regenerative medicine, etc., manufacture and sale of goods, acquisition, possession, licensing, transfer and management of intellectual property, and early practical application of regenerative medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Masayo Takahashi
Chief Financial Officer
Takuma Fukuda
Chief Operating Officer
Tomoki Otani
Chief Technical Officer
Seiji Hori
Browse more venture capital transactions:
Prev: 11/16/2023: Kinto venture capital transaction
Next: 11/16/2023: Crisp venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs